Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain.
Schkeryantz
Jeffrey M
JM
Lilly Research Labs, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285, USA. jschkaryantz@Lilly.com
Kingston
Ann E
AE
Johnson
Michael P
MP
D000700:Analgesics / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors* / Q000502:physiology
D000700:Analgesics; D018094:Receptors, Metabotropic Glutamate; C104077:metabotropic glutamate receptor type 1